Protective role of heparin/heparan sulfate on oxalate-induced changes in cell morphology and intracellular Ca2+.
Alterations in intracellular Ca2+ ([Ca2+]i) are generally associated with cellular distress. Oxalate-induced cell injury of the renal epithelium plays an important role in promoting CaOx nephrolithiasis. However, the degree of change in intracellular free calcium ions in renal epithelial cells during oxalate exposure remains unclear. The aim of this study is to determine whether acute short-term exposure to oxalate produces morphological changes in the cells, induces a change in cytosolic Ca2+ levels in renal tubular epithelial cells and whether the application of extracellular glycosaminoglycans (GAGs) prevents these changes. Cultured Mardin-Darby canine kidney cells were exposed to oxalate, and changes in cytosolic Ca2+ were determined under various conditions. The effect of heparin and heparan sulfate (HS) during oxalate exposure was examined. The change in the GAG contents of the culture medium was also determined. Transmission electron microscopy (TEM) was performed for morphological analysis. The degree of change in cytosolic Ca2+ strongly correlated with oxalate concentration. Cytosolic Ca2+ levels decreased in parallel with an increase in the concentration of oxalate. However, this decrease was strongly inhibited by pretreatment with heparin or HS. TEM revealed cytoplasmic vacuolization, the appearance of flocculent material and mitochondrial damage after oxalate exposure. On the other hand, pretreatment with heparin or HS completely blocked these morphological changes. The present data suggest that acute exposure to a high concentration of oxalate challenges the renal cells, diminishes their viability and induces changes in cytosolic Ca2+ levels. Heparin and HS, which are known as potent inhibitors of CaOx crystallization, may also prevent oxalate-induced cell changes by stabilizing the cytosolic Ca2+ level.
Iida
Shizuka
S
Department of Urology, Kurume University School of Medicine, 67 Asahi-machi, Kurume 830-0011, Japan. iidas@med.kurume-u.ac.jp
Ishimatsu
Masaru
M
Chikama
Shyumei
S
Inoue
Michiro
M
Matsuoka
Kei
K
Akasu
Takashi
T
Noda
Shinshi
S
Khan
Saeed R
SR
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002129:Calcium Oxalate / Q000494:pharmacology*; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D019610:Cytoprotection; D004285:Dogs; D045604:Extracellular Fluid / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology*; D006497:Heparan Sulfate / Q000494:pharmacology*; D007425:Intracellular Membranes / Q000378:metabolism*; D007668:Kidney / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D007669:Kidney Calculi / Q000517:prevention & control; D008854:Microscopy, Electron
D002118:Calcium; D002129:Calcium Oxalate; D006493:Heparin; D006497:Heparan Sulfate